CAMK1D(CAMK1d)
Sign in to save this workspaceUniProt Q8IU85 · PDB · AlphaFold · Substrate: Autocamtide 2 + Ca-CaM · Clone: full length
Top inhibitors
| # | Drug | Inhibition | Residual | KISS | Gini |
|---|---|---|---|---|---|
| 1 | Bosutinib | 83.2% | 16.8% | 87.22 | 0.555 |
| 2 | Brigatinib | 67.7% | 32.3% | 82.96 | 0.513 |
| 3 | Nintedanib | 64.6% | 35.4% | 90.23 | 0.608 |
| 4 | Pacritinib | 56.0% | 44.0% | 88.64 | 0.452 |
| 5 | Baricitinib | 48.8% | 51.2% | 97.99 | 0.616 |
| 6 | Gilteritinib | 42.3% | 57.7% | 88.97 | 0.506 |
| 7 | Midostaurin | 40.2% | 59.8% | 78.64 | 0.500 |
| 8 | Abemaciclib | 34.1% | 65.9% | 91.48 | 0.563 |
| 9 | Sunitinib | 33.4% | 66.6% | 91.73 | 0.524 |
| 10 | Dabrafenib | 33.1% | 66.9% | 94.74 | 0.633 |
| 11 | Pemigatinib | 31.8% | 68.2% | 98.23 | 0.718 |
| 12 | Ruxolitinib | 27.2% | 72.8% | 98.25 | 0.592 |
| 13 | Fedratinib | 24.2% | 75.8% | 96.21 | 0.576 |
| 14 | Alectinib | 23.3% | 76.7% | 95.49 | 0.651 |
| 15 | Infigratinib | 22.1% | 77.9% | 98.24 | 0.710 |
| 16 | Neratinib | 21.0% | 79.0% | 93.18 | 0.597 |
| 17 | Selpercatinib | 19.5% | 80.5% | 96.72 | 0.635 |
| 18 | Mobocertinib | 16.6% | 83.4% | 97.22 | 0.757 |
| 19 | Ceritinib | 16.2% | 83.8% | 95.44 | 0.618 |
| 20 | Lazertinib | 16.0% | 84.0% | 97.47 | 0.674 |
Paralog block
No paralog group registered for this kinase.
EMT expression
- Mesenchymal log2(TPM+1): 1.91
- Epithelial log2(TPM+1): 1.86
- Fold change: 0.06
- Status: No significant change
Selectivity landscape vs inhibition on CAMK1D
Each point is one of the 92 approved drugs; color = inhibition % on CAMK1D.
3D structure
Embedded NGL viewer pulls a representative PDB entry (or AlphaFold model if no experimental structure is registered). Heavy bundle — loaded only on demand.
Annotations
Sign in to read and post annotations.
Loading…